Novavax Inc (NVAX)
7.10
-0.12
(-1.66%)
USD |
NASDAQ |
Nov 15, 10:27
Novavax Free Cash Flow (Quarterly): 311.14M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 311.14M |
| March 31, 2024 | -90.80M |
| December 31, 2023 | -185.86M |
| September 30, 2023 | -58.05M |
| June 30, 2023 | -179.72M |
| March 31, 2023 | -349.15M |
| December 31, 2022 | -139.88M |
| September 30, 2022 | -68.23M |
| June 30, 2022 | -195.48M |
| March 31, 2022 | -105.34M |
| December 31, 2021 | -358.77M |
| September 30, 2021 | -154.33M |
| June 30, 2021 | 129.26M |
| March 31, 2021 | 649.30M |
| December 31, 2020 | -170.58M |
| September 30, 2020 | -15.22M |
| June 30, 2020 | 111.87M |
| March 31, 2020 | -23.23M |
| December 31, 2019 | -23.96M |
| September 30, 2019 | -32.62M |
| June 30, 2019 | -30.49M |
| March 31, 2019 | -51.41M |
| December 31, 2018 | -45.78M |
| September 30, 2018 | -33.91M |
| June 30, 2018 | -40.28M |
| Date | Value |
|---|---|
| March 31, 2018 | -66.22M |
| December 31, 2017 | -44.04M |
| September 30, 2017 | -45.40M |
| June 30, 2017 | -13.64M |
| March 31, 2017 | -45.58M |
| December 31, 2016 | -67.74M |
| September 30, 2016 | -66.32M |
| June 30, 2016 | -67.56M |
| March 31, 2016 | -75.35M |
| December 31, 2015 | -59.37M |
| September 30, 2015 | -32.94M |
| June 30, 2015 | -16.70M |
| March 31, 2015 | -35.35M |
| December 31, 2014 | -22.16M |
| September 30, 2014 | -18.90M |
| June 30, 2014 | -11.90M |
| March 31, 2014 | -21.32M |
| December 31, 2013 | -13.29M |
| September 30, 2013 | -16.48M |
| June 30, 2013 | -9.248M |
| March 31, 2013 | -12.12M |
| December 31, 2012 | -5.391M |
| September 30, 2012 | -5.757M |
| June 30, 2012 | -6.43M |
| March 31, 2012 | -4.992M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-358.77M
Minimum
Dec 2021
649.30M
Maximum
Mar 2021
-48.26M
Average
-90.80M
Median
Mar 2024
Free Cash Flow (Quarterly) Benchmarks
| Pfizer Inc | 6.063B |
| Moderna Inc | -1.717B |
| Baxter International Inc | 229.00M |
| Inovio Pharmaceuticals Inc | -28.66M |
| AIM ImmunoTech Inc | -3.237M |